BioCentury
ARTICLE | Clinical News

AVI-5038 regulatory update

January 4, 2010 8:00 AM UTC

EMEA's Committee for Orphan Medical Products (COMP) granted Orphan Drug designation to AVI-5038 to treat Duchenne muscular dystrophy (DMD). The neugene antisense oligonucleotide targeting exon 50 of ...